RBC Capital Downgrades Merck & Co to Sector Perform, Raises Price Target to $150
Merck & Co., Inc.
Merck & Co., Inc. MRK | 0.00 |
RBC Capital analyst Trung Huynh downgrades Merck & Co (NYSE:
MRK) from Outperform to Sector Perform and raises the price target from $142 to $150.
